【参考文献】
1 郭彦.青光眼视神经损伤与视神经保护.食品与药品 2005:7(05A):1723
2 Osborne NN, Chidlow G, Wood J, et al. Some current ideas on the pathogenesis and the role of neuroprotection in glaucomatous optic neuropathy. Eur J Ophthalmol 2003;3:S1926
3 Christopher G. Strategies for europrotectionm advances in glaucoma therapy. J Glaucoma 2001;10(5):7880
4 Ashkenazi A, Dixit VM. Death receptors:signaling and modulation. Science 1998;281:13051308
5 Adams JM,Cory S.The bcl 2 protein family: arbiters of cell survival.Science 1998;281:13221326
6 Chaudhary P,Ahmed F,Quebada P, et al. Caspase inhibitors block the retinal ganglion cell death following optic nerve transection. Brain Res 1999;67:3645
7 Chen MS, Huber AB, Haar ME, et al. NogoA is a myelinassociated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN1. Nature 2000;403:434439
8 GrandPre T, Li S, Strittmatter SM. Nogo 66 receptor antagonist peptide promotes axonal regeneration. Nature 2002; 417:547551
9 GrandPre T, Li S, Strittmatter SM. Nogo66 receptor antagonist peptide promotes axonal regeneration. Nature 2002;417(6888):547551
10雷季良,杨磊,赵君鹏,等.正常和视神经损伤后Nogo(N18)在金黄地鼠视网膜的表达. 解剖学报 2003;34(6):596601
11 McKinnon SJ, Lehman DM, Kerrigan BLA, et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 2002;43:10771087
12 Chaudhary P,Ahmed F,Quebada P, et al.Caspase inhibitors block the retinal ganglion cell death following optic nerve transection. Brain Res 1999;67:3645
13 Patil K, Sharma SC. Broad spectrum caspase inhibitor rescues retinal ganglion cells after ischemia. NeuroReport 2004;15(6):981984
14 Junk AK, Mammis A, Savitz SI, et al. Erythropoietin administration protects retinal neurons from acute ischemiareperfusion injury. Proc Natl Acad Sci 2002;99:1065910664
15戴毅.红细胞生成素研究新进展.国外医学临床生化与检验分册 2002;23(3):144146
16 Yamasaki M, Mishima HK, Yamashita H. Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res 2005;1050(12):1526
17 Inomata Y, Hirata A, Takahashi E, et al. Elevated erythropoietin in vitreous with ischemic retinal diseases. Neuroreport 2004;15(5):877879
18 Dreyer EB. A proposed role for excitotoxicity in glaucoma. J Glaucoma 1998;7:6267
19 Li BX, De AY. Changes of excitatory amino acids in ischemic retinal damage. Rec Adv Ophthalmol 2005;25:2426
20 Ullian EM, Barkis WB, Chen S, et al. Invulnerability of retinal ganglion cells to NMDA excitotoxicity. Mol Cell Neurosci 2004;26:544 557
21 WoldeMussie, Elizabeth PhD, Yoles,et al. Neuroprotective Effect of Memantine in Different Retinal Injury Models. J Glaucoma 2002;11(6):474480
22 Tomida I, Pertwee RG, AzuaraBlanco A. Cannabinoids and glaucoma. Br J Ophthalmol 2004;88(5):708713
23 Masaaki O, Shinichiro S, Yasuhiro F. Ocular distribution after topical instillation and potential neuroprotective effect after intravitreal injection of the calcium channel blocker iganipidine. Curr Eye Res 2005;30:309317
24 Saito S,Ohashi M,Naito A.Neuroprotective effect of the novel Na+/Ca2+ channel blocker NS7 on rat retinal ganglion cells. Jph J Ophthalmology 2005;49(5):371376
25 Fabian M, Georg M, Joanna H. Singledose nimodipine normalizes impaired retinal circulation in normal Tension Glaucoma.J Glaucoma 2004;13(2):158162
26 Morgan J, Caprioli J, Koseki Y. Nitric oxide mediates excitotoxic and anoxic damage in rat retinal ganglion cells cocultured with astroglia. Arch Ophthalmol 1999;117:15241529
27胡怀彬.青光眼视神经保护治疗的进展.眼科 2002;11(5):308312
28 Shareef S, Sawada A, Neufeld AH. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Natl Acad Sci USA 1999;96(17):9944
29 Cheon EW, Park CH, Kang SS, et al. Change in endothelial nitric oxide synthase in the rat retina following transient ischemia. Neuroreport 2003;14(3):329333
30 Pang IH, Johnson EC, Jia L, et al. Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressureinduced optic nerve damage. Invest Ophthalmol Vis Sci 2005;46:13131321
31 Quigley HA, McKinnon SJ, Zack DJ, et al. Retrograde axonal transport of bdnf in retinal ganglion cells is blocked by acute iop elevation in rats. Invest Ophthalmol Vis Sci 2000;41:34603466
32 Martin KR, Quigley HA, Zack DJ. Gene therapy with brainderived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Invest Ophthalmol Vis Sci 2003;44(10):43574365
33 Simon1 B, Harris NG, Pinilla G.Traumatic optic neuropathy in a rat model the effect of traumatic brain injury (TBI) on retinal ganglion cells (RGCs) survival after optic nerve crush, and the role of brain derived neurotrophic factor (BDNF) in immune mediated neuroprotection. Invest Ophthalmol Vis Sci 2005;46:EAbstract 666
34 Huang SP, Lin PK, Liu JH, et al. Intraocular gene tansfer of ciliary neurotrophic factor rescues photoreceptor for degeneration in RCS rats. J Bionmed Sci 2004;11:3748
35杨小丽, 顾青.视神经损伤时视网膜睫状神经营养因子受体的表达.眼科研究 2005;23(2):195197
36 Frasson M, Picaud S,Léveillard T, et al. Glial cell linederived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse. Invest Ophthalmol Vis Sci 1999;40:27242734
37 Wu WC, Lai CC, Chen SL, et al. Longterm safety of GDNF gene delivery in the retina. Current Eye Research 2005;30(8):715722
38 Johnson EC, Deppmeier LM, Wentzien SK, et al. Chronology of optic nerve head and retinal responses to elevated intraocular pressure. Invest Ophthalmol Vis Sci 2000;41:431 442
39 Maruyama I, Nakazawa M, Ohguro H. Autoimmune mechanisms in molecular pathology of glaucomatous optic neuropathy. Nippon Ganka Gakkai Zasshi 2001;105:205212
40 Grus FH, Joachim SC, Hoffmann EM, et al. Complex autoantibody repertoires in patients with glaucoma. Mol Vis 2004;10:132137
41 Tezel G, Edward DP, Wax MB. Serum autoantibodies nto optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol 1999;117:917 924
42 Anderson MG, Libby RT, Gould DB, et al. Highdose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma. Proc Natl Acad Sci USA 2005;102:4566 4571
43 Schwartz M, Kipnis J, Avidan H. Regulation of immunedependent neuroprotection for arresting neuronal degeneration in optic neuropathies. Invest Ophthalmol Vis Sci 2003;44:745
44 Bakalash S, Kessler A, Mizrahi T, et al. Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma. Invest Ophthalmol Vis Sci 2003;44(8):33743381
45 Schwartz M.Vaccination for glaucoma:dream or reality?Brain Res Bull 2004;62(6):481484
46 Kipnis J, Avidan H, Markovich Y, et al. Lowdose gammairradiation promotes survival of injured neurons in the central nervous system via homeostasisdriven proliferation of T cells. Eur J Neurosci 2004;19:1191 1198
47 Cheon EW, Park CH, Kang SS, et al. Betaxolol attenuates retinal ischemia/reperfusion damage in the rat. Neuroreport 2003;14(15):19131917
48 Wheeler L, WoldeMussie E, Lai R. Role of alpha2 agonists in neuroprotection. Surv Ophthalmol 2003;48(1):S4751
49 WoldeMussie E, Ruiz G, Wijono M, et al. Neuroprotection of retinal ganglion cells by brimonidine in rats with laserinduced chronic ocular hypertension. Invest Ophthalmol Vis Sci 2001;42:2849 2855
50 AvilesTrigueros M,MayorTorroglosa S,GarciaAviles A,et al.Transient ischemia of the retina results in massive degeneration of the retinotectal projection: longterm neuroprotection with brimonidine. Exp Neurol 2003;184:767777
51 Donello JE, Padillo EU, Webster ML, et al. Alpha(2)adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. J Pharmacol Exp Ther 2001;296:216223
52 Kenji K, Yoko I. Neuroprotective effects of nipradilol on purified cultured retinal ganglion cells. J Glaucoma 2002;11(3):231238
53 Ando A, Yamazaki Y, Kaneko S. Cytoprotection by nipradilol,an antiglaucomatous agent,via downregulation of apoptosis related gene expression and activation of NFkappaB. Exp Eye Res 2005;80(4):501507
54 Lchikawa M,Okada Y,Asai Y, et al. Effects of topically instilled bunazosin,an alpha1adrenoceptor antagonist,on constrictions induced by phenylephrine and ET1 in rabbit retinal arteries.Invest Ophthalmol Vis Sci 2004;55(11):40414048
55 Goto W, Lchikawa M, Tanaka E, et al. Bunazosin hydrochloride reduces glutamateinduced neurotoxicity in rat primary retinal cultures. Brain Res 2004;1003(12):130137
56张跃红,牛膺筠,王红筠,等.低氧预适应对小鼠视网膜光感受器细胞光损伤的防护作用.中华眼科杂志 2005;41:631635
57 QuinonesHinojosa A,Malek JY, Ames A 3rd, et al. Metabolic effects of hypothermia and its neuroprotective effects on the recovery of metabolic and electrophysiological function in the ischemic retina in vitro. Neurosurgery 2003;52(5):11781187
58 Koubova J, Guarente L. How does calorie restriction work? Genes 2003;17(3):313321
59 Lan YW, Ishii Y, Palmer KE, et al. 2DeoxyDglucose protects retinal ganglion cells against excitotoxicity. Neuroreport 2003;14(18):23692372
60 Shimazawa M, Yamashima T, Agarwal N, et al. Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage. Brain Res 2005;1053(12):185194
61 Swanson KI, Schileve CR, Lieven CJ, et al. Neuroprotective effect of sulfhydryl reduction in a rat optic nerve crush model. Invest Ophthalmol Vis Sci 2005;46:37373741
62范军华,蒋华.原发性青光眼视神经损害的发生机制.国际眼科杂志 2006;6(2):428432
63 Goto W, Oku H, Okuno T, et al. Amelioration of endothelin1induced optic nerve head ischemia by topical bunazosin. Curr Eye Res 2005;30(2):8191
64 Nakatani M, Taki C, Goto K. Neuroprotective effect of adenosine on calibrated optic nerve injury in rats. Invest Ophthalmol Vis Sci 2003;44:EAbstract 5202B861
65 Oshitari T,Fujimoto N,AdachiUsami E.Citicoline has a protective effect on damaged retinal ganglion cells in mouse culture retina. Neuroreport 2002;13(16):21092111
66 Rejdak R, Toczolowski J, Solski J, et al. Citicoline treatment increases retinal dopamine content in rabbits. Ophthalmic Res 2002;34(3):146149
67 Yin Y, Cui Q, Li Y, et al. Macrophagederived factors stimulate optic nerve regeneration. J Neurosci 2003;23(6):22842293
68 Morimoto T,Miyoshi T,Fujikado T,et al. Electrical stimulation enhances the survival of axotomized retinal ganglion cells in vivo. Neuroreport 2002;13(2):227230 上一页 [1] [2] [3] |